Who's buying Indaptus Therapeutics, Inc.?

INDP insider buying, 13F and 13D filings

• Oct 22, 202613D stake (no activist plan)
  Sino Lion Ventures Ltd (+1): Amended Schedule 13D: 25.3% stake
  The information set forth in Item 4 in the Initial Schedule 13D is incorporated herein by reference. This Amendment No. 3 is being filed to report a decrease of more than 1% in the percentage of the outstanding Common Stock beneficially owned by the Reporting Persons, resulting s…
  View the filing on SEC EDGAR ↗
• Oct 22, 202613D stake (no activist plan)
  Dai Junyi: Amended Schedule 13D: 7.3% stake
  The information set forth in Item 4 in the Initial Schedule 13D is incorporated herein by reference. This Amendment No. 3 is being filed to report a decrease of more than 1% in the percentage of the outstanding Common Stock beneficially owned by the Reporting Person, resulting so…
  View the filing on SEC EDGAR ↗

Signals come from SEC filings: Form 4 (insiders, filed within 2 business days), 13F (fund holdings, up to 45 days after quarter end) and Schedule 13D (5%+ activist stakes). This page reports what the filings show; it is not investment advice.